Bridgeway Capital Management’s Cyclerion Therapeutics CYCN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-5,750
| Closed | -$49.9K | – | 1398 |
|
|
2023
Q1 | $49.9K | Hold |
5,750
| – | – | ﹤0.01% | 1311 |
|
|
2022
Q4 | $75.5K | Hold |
5,750
| – | – | ﹤0.01% | 1256 |
|
|
2022
Q3 | $99K | Hold |
5,750
| – | – | ﹤0.01% | 1270 |
|
|
2022
Q2 | $63K | Hold |
5,750
| – | – | ﹤0.01% | 1271 |
|
|
2022
Q1 | $128K | Buy |
+5,750
| New | +$128K | ﹤0.01% | 1238 |
|
|
2021
Q2 | – | Sell |
-5,980
| Closed | -$334K | – | 1349 |
|
|
2021
Q1 | $334K | Buy |
5,980
+1,900
| +47% | +$106K | 0.01% | 1205 |
|
|
2020
Q4 | $250K | Sell |
4,080
-1,470
| -26% | -$90.1K | 0.01% | 1162 |
|
|
2020
Q3 | $675K | Buy |
5,550
+2,500
| +82% | +$304K | 0.02% | 794 |
|
|
2020
Q2 | $361K | Buy |
+3,050
| New | +$361K | 0.01% | 973 |
|